Soluble TWEAK independently predicts atherosclerosis in renal transplant patients

BMC Nephrology

Table 2 sTWEAK, hs-CRP, NLR and CIMT values of the healthy subjects and renal transplant patients

Parameters	Healthy subjects Median Median (IQR) (n=25)	Renal transplant patients (n=70) Median (IQR)	P	ρ (Ρ)^a	ρ (Ρ)^b
hs-CRP (mg/L)*	3,3 (2.25-5.8)	8.9 (4.97-14)	<0.0001	0,15 (p=0.25)	0.09 (p=0.46)
sTWEAK (pg/mL)*	457 (320.5-537.8)	388.9 (324.5-426.9)	0.01	-	0.81 (p<0.0001)
NLR	1.16 (0.97-1.5)	2.18 (1.4-2.8)	0.001	0.37 (p=0.002)	0.33 (p=0.006)
CIMT (mm)	0.4 (0.4-0.5)	0.5 (0.4-0.9)	<0.0001	0.81 (p<0.0001)	-

sTWEAK soluble TNF-like weak inducer of apoptosis, NLR neutrophil-to-lymphocyte ratio, CIMT carotid intima media thickness, hs-CRP high sensitive C-reactive protein, IQR interquartile range, * represents the variables in median (IQR).
^a Spearman rank univariate analysis for sTWEAK in renal transplant patients.
^b Spearman rank univariate analysis for CIMT in renal transplant patients.

ISSN: 1471-2369